- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sopharma (BGSFA)
Sopharma stock price live, this page displays BB BGSFA stock exchange data. View the BGSFA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sopharma real time stock price chart below.
What Is the Sopharma Stock Price Today?
The Sopharma stock price today is 2.480.
What Is the Stock Symbol for Sopharma?
The stock symbol for Sopharma is ""BGSFA.""
What Stock Exchange Does Sopharma Trade On?
Sopharma is listed and trades on the Sofia stock exchange.
Is Sopharma a Good Stock to Buy?
Determining whether Sopharma—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BGSFA quote. (ISIN: BG11SOSOBT18)
What Is the Sopharma Stock Price Today?
The Sopharma stock price today is 2.480.
What Is the Stock Symbol for Sopharma?
The stock symbol for Sopharma is ""BGSFA.""
What Stock Exchange Does Sopharma Trade On?
Sopharma is listed and trades on the Sofia stock exchange.
Is Sopharma a Good Stock to Buy?
Determining whether Sopharma—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BGSFA quote. (ISIN: BG11SOSOBT18)
2.480
0.000(0.00%)
Delayed Data·
Fair Value
An estimate of a Sopharma AD's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.450
2.480
52 wk Range
2.300
7.340
BGSFA Scorecard
Full Analysis
Valuation implies a strong free cash flow yield
Earnings results expected in 3 days
1/3
Fair Value
An estimate of a Sopharma AD's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.4502.480
52 wk Range
2.3007.340
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.23%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.23%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BGSFA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Sopharma AD's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Sopharma Company Profile
Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. It offers Carsil to treat liver disease; Tempalgin, a painkiller; Analgin, a pain reliever; Tabex, a drug used for smoking secession; Tribestan, a drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin for use in the peripheral nervous system; Methylprednisolon for severe allergies and life-threatening conditions; Vitamin C; Valeriana to reduce the stress; and medical devices, such as gauzes, compresses, and dressing. The company also provides food supplements; medicinal and cosmetic products, including plasters, bandages, herbal cosmetics, and sanitary-hygiene products; concentrates for hemodialysis; and prescription medicines, and OTC and veterinary medical products. In addition, the company distributes pharmaceuticals, medical supplies, sanitary materials, vitamins, food supplements, and cosmetics; and provides contract manufacturing services; packaging services; and product development services. Further, it is involved in trading of pharmaceuticals; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; purchases, grows, produces, and trades in herbs and medicinal plant; and provision of public opinion research services. Additionally, the company engages in the offline and online retail trade of medicinal products and medical equipment; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities. Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.
Compare BGSFA to Peers and Sector
Metrics to compare | BGSFA | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipBGSFAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 14.0x | 14.6x | −0.5x | |
PEG Ratio | −0.58 | 0.01 | 0.00 | |
Price/Book | 1.4x | 2.8x | 2.6x | |
Price / LTM Sales | 0.5x | 2.2x | 3.3x | |
Upside (Analyst Target) | - | 31.8% | 38.7% | |
Fair Value Upside | Unlock | 11.0% | 5.0% | Unlock |
Earnings
Latest Release
May 29, 2025
EPS / Forecast
0.24 / --
Revenue / Forecast
644.00M / --
FAQ
What Stock Exchange Does Sopharma AD Trade On?
Sopharma AD is listed and trades on the Sofia Stock Exchange stock exchange.
What Is the Stock Symbol for Sopharma AD?
The stock symbol for Sopharma AD is "BGSFA."
What Is the Sopharma AD Market Cap?
As of today, Sopharma AD market cap is 1.24B.
What Is Sopharma AD's Earnings Per Share (TTM)?
The Sopharma AD EPS (TTM) is 0.17.
When Is the Next Sopharma AD Earnings Date?
Sopharma AD will release its next earnings report on 29 Aug 2025.
From a Technical Analysis Perspective, Is BGSFA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Sopharma AD Stock Split?
Sopharma AD has split 2 times.
How Many Employees Does Sopharma AD Have?
Sopharma AD has 6099 employees.
What is the current trading status of Sopharma AD (BGSFA)?
As of 27 Aug 2025, Sopharma AD (BGSFA) is trading at a price of 2.48, with a previous close of 5.80. The stock has fluctuated within a day range of 2.45 to 2.48, while its 52-week range spans from 2.30 to 7.34.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.